Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 133 to 142 of 142 entries
Sorted by: Best Match Show Resources per page
[No title available]

MMW Fortschritte der Medizin

Westphal K.
PMID: 28168454
MMW Fortschr Med. 2017 Feb;159(2):71. doi: 10.1007/s15006-017-9230-4.

No abstract available.

Cite
Westphal K. Dreifachkombination fördert Compliance. . MMW Fortschr Med. 2017;159(2):71doi: 10.1007/s15006-017-9230-4.
Westphal, K. (2017). Dreifachkombination fördert Compliance. . MMW Fortschritte der Medizin, 159(2), 71. https://doi.org/10.1007/s15006-017-9230-4
Westphal, Kirsten. "Dreifachkombination fördert Compliance." . MMW Fortschritte der Medizin vol. 159,2 (2017): 71. doi: https://doi.org/10.1007/s15006-017-9230-4
Westphal K. Dreifachkombination fördert Compliance. . MMW Fortschr Med. 2017 Feb;159(2):71. doi: 10.1007/s15006-017-9230-4. German. PMID: 28168454.
Copy Download .nbib Format: NLM
Brazilian guidelines for the management of brain-dead potential organ donors. The task force of the AMIB, ABTO, BRICNet, and the General Coordination of the National Transplant System.

Annals of intensive care

Westphal GA, Robinson CC, Cavalcanti AB, Gonçalves ARR, Guterres CM, Teixeira C, Stein C, Franke CA, da Silva DB, Pontes DFS, Nunes DSL, Abdala E, Dal-Pizzol F, Bozza FA, Machado FR, de Andrade J, Cruz LN, de Azevedo LCP, Machado MCV, Rosa RG, Manfro RC, Nothen RR, Lobo SM, Rech TH, Lisboa T, Colpani V, Falavigna M.
PMID: 33315161
Ann Intensive Care. 2020 Dec 14;10(1):169. doi: 10.1186/s13613-020-00787-0.

OBJECTIVE: To contribute to updating the recommendations for brain-dead potential organ donor management.METHOD: A group of 27 experts, including intensivists, transplant coordinators, transplant surgeons, and epidemiologists, joined a task force formed by the General Coordination Office of the National...

Cite
Westphal GA, Robinson CC, Cavalcanti AB, et al. Brazilian guidelines for the management of brain-dead potential organ donors. The task force of the AMIB, ABTO, BRICNet, and the General Coordination of the National Transplant System. Ann Intensive Care. 2020;10(1):169doi: 10.1186/s13613-020-00787-0.
Westphal, G. A., Robinson, C. C., Cavalcanti, A. B., Gonçalves, A. R. R., Guterres, C. M., Teixeira, C., Stein, C., Franke, C. A., da Silva, D. B., Pontes, D. F. S., Nunes, D. S. L., Abdala, E., Dal-Pizzol, F., Bozza, F. A., Machado, F. R., de Andrade, J., Cruz, L. N., de Azevedo, L. C. P., Machado, M. C. V., Rosa, R. G., Manfro, R. C., Nothen, R. R., Lobo, S. M., Rech, T. H., Lisboa, T., Colpani, V., & Falavigna, M. (2020). Brazilian guidelines for the management of brain-dead potential organ donors. The task force of the AMIB, ABTO, BRICNet, and the General Coordination of the National Transplant System. Annals of intensive care, 10(1), 169. https://doi.org/10.1186/s13613-020-00787-0
Westphal, Glauco Adrieno, et al. "Brazilian guidelines for the management of brain-dead potential organ donors. The task force of the AMIB, ABTO, BRICNet, and the General Coordination of the National Transplant System." Annals of intensive care vol. 10,1 (2020): 169. doi: https://doi.org/10.1186/s13613-020-00787-0
Westphal GA, Robinson CC, Cavalcanti AB, Gonçalves ARR, Guterres CM, Teixeira C, Stein C, Franke CA, da Silva DB, Pontes DFS, Nunes DSL, Abdala E, Dal-Pizzol F, Bozza FA, Machado FR, de Andrade J, Cruz LN, de Azevedo LCP, Machado MCV, Rosa RG, Manfro RC, Nothen RR, Lobo SM, Rech TH, Lisboa T, Colpani V, Falavigna M. Brazilian guidelines for the management of brain-dead potential organ donors. The task force of the AMIB, ABTO, BRICNet, and the General Coordination of the National Transplant System. Ann Intensive Care. 2020 Dec 14;10(1):169. doi: 10.1186/s13613-020-00787-0. PMID: 33315161; PMCID: PMC7736434.
Copy Download .nbib Format: NLM
[No title available]

MMW Fortschritte der Medizin

Westphal K.
PMID: 34811695
MMW Fortschr Med. 2021 Nov;163:90. doi: 10.1007/s15006-021-0568-2.

No abstract available.

Cite
Westphal K. Therapieumstellung bessert Risikoprofil. . MMW Fortschr Med. 2021;163:90doi: 10.1007/s15006-021-0568-2.
Westphal, K. (2021). Therapieumstellung bessert Risikoprofil. . MMW Fortschritte der Medizin, 16390. https://doi.org/10.1007/s15006-021-0568-2
Westphal, Kirsten. "Therapieumstellung bessert Risikoprofil." . MMW Fortschritte der Medizin vol. 163 (2021): 90. doi: https://doi.org/10.1007/s15006-021-0568-2
Westphal K. Therapieumstellung bessert Risikoprofil. . MMW Fortschr Med. 2021 Nov;163:90. doi: 10.1007/s15006-021-0568-2. German. PMID: 34811695.
Copy Download .nbib Format: NLM
Cyclic, Hydrophobic Hexapeptide Fusahexin Is the Product of a Nonribosomal Peptide Synthetase in .

Journal of natural products

Westphal KR, Bachleitner S, Severinsen MM, Brundtø ML, Hansen FT, Sørensen T, Wollenberg RD, Lysøe E, Studt L, Sørensen JL, Sondergaard TE, Wimmer R.
PMID: 34292732
J Nat Prod. 2021 Aug 27;84(8):2070-2080. doi: 10.1021/acs.jnatprod.0c00947. Epub 2021 Jul 22.

The plant pathogenic fungus

Cite
Westphal KR, Bachleitner S, Severinsen MM, et al. Cyclic, Hydrophobic Hexapeptide Fusahexin Is the Product of a Nonribosomal Peptide Synthetase in . J Nat Prod. 2021;84(8):2070-2080doi: 10.1021/acs.jnatprod.0c00947.
Westphal, K. R., Bachleitner, S., Severinsen, M. M., Brundtø, M. L., Hansen, F. T., Sørensen, T., Wollenberg, R. D., Lysøe, E., Studt, L., Sørensen, J. L., Sondergaard, T. E., & Wimmer, R. (2021). Cyclic, Hydrophobic Hexapeptide Fusahexin Is the Product of a Nonribosomal Peptide Synthetase in . Journal of natural products, 84(8), 2070-2080. https://doi.org/10.1021/acs.jnatprod.0c00947
Westphal, Klaus R, et al. "Cyclic, Hydrophobic Hexapeptide Fusahexin Is the Product of a Nonribosomal Peptide Synthetase in ." Journal of natural products vol. 84,8 (2021): 2070-2080. doi: https://doi.org/10.1021/acs.jnatprod.0c00947
Westphal KR, Bachleitner S, Severinsen MM, Brundtø ML, Hansen FT, Sørensen T, Wollenberg RD, Lysøe E, Studt L, Sørensen JL, Sondergaard TE, Wimmer R. Cyclic, Hydrophobic Hexapeptide Fusahexin Is the Product of a Nonribosomal Peptide Synthetase in . J Nat Prod. 2021 Aug 27;84(8):2070-2080. doi: 10.1021/acs.jnatprod.0c00947. Epub 2021 Jul 22. PMID: 34292732.
Copy Download .nbib Format: NLM
There is more to it than just congenital heart defects - The phenotypic spectrum of TAB2-related syndrome.

Gene

Westphal DS, Mastantuono E, Seidel H, Riedhammer KM, Hahn A, Vill K, Wagner M.
PMID: 34995729
Gene. 2022 Jan 05;814:146167. doi: 10.1016/j.gene.2021.146167. Epub 2022 Jan 05.

BACKGROUND: Congenital heart defects (CHD) are the most common birth defect and disease-causing variant in TAB2 have found to be associated with isolated CHD. Recently, it became evident that pathogenic, mostly loss-of-function variants in TAB2 can also cause syndromic...

Cite
Westphal DS, Mastantuono E, Seidel H, et al. There is more to it than just congenital heart defects - The phenotypic spectrum of TAB2-related syndrome. Gene. 2022;814:146167doi: 10.1016/j.gene.2021.146167.
Westphal, D. S., Mastantuono, E., Seidel, H., Riedhammer, K. M., Hahn, A., Vill, K., & Wagner, M. (2022). There is more to it than just congenital heart defects - The phenotypic spectrum of TAB2-related syndrome. Gene, 814146167. https://doi.org/10.1016/j.gene.2021.146167
Westphal, Dominik S, et al. "There is more to it than just congenital heart defects - The phenotypic spectrum of TAB2-related syndrome." Gene vol. 814 (2022): 146167. doi: https://doi.org/10.1016/j.gene.2021.146167
Westphal DS, Mastantuono E, Seidel H, Riedhammer KM, Hahn A, Vill K, Wagner M. There is more to it than just congenital heart defects - The phenotypic spectrum of TAB2-related syndrome. Gene. 2022 Jan 05;814:146167. doi: 10.1016/j.gene.2021.146167. Epub 2022 Jan 05. PMID: 34995729.
Copy Download .nbib Format: NLM
Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection.

ESC heart failure

Nguyen TD, Mall G, Westphal JG, Weingärtner O, Möbius-Winkler S, Schulze PC.
PMID: 34536056
ESC Heart Fail. 2021 Dec;8(6):4710-4714. doi: 10.1002/ehf2.13613. Epub 2021 Sep 18.

We describe a case of a 20-year-old healthy man developing chest pain and classical symptoms of vaccine reactogenicity 12 h after receiving the first dose of mRNA-1273 (Moderna). Cardiac troponin T was increased, and subepicardial inflammation and focal contractile...

Cite
Nguyen TD, Mall G, Westphal JG, et al. Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection. ESC Heart Fail. 2021;8(6):4710-4714doi: 10.1002/ehf2.13613.
Nguyen, T. D., Mall, G., Westphal, J. G., Weingärtner, O., Möbius-Winkler, S., & Schulze, P. C. (2021). Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection. ESC heart failure, 8(6), 4710-4714. https://doi.org/10.1002/ehf2.13613
Nguyen, Tien Dung, et al. "Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection." ESC heart failure vol. 8,6 (2021): 4710-4714. doi: https://doi.org/10.1002/ehf2.13613
Nguyen TD, Mall G, Westphal JG, Weingärtner O, Möbius-Winkler S, Schulze PC. Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection. ESC Heart Fail. 2021 Dec;8(6):4710-4714. doi: 10.1002/ehf2.13613. Epub 2021 Sep 18. PMID: 34536056; PMCID: PMC8652969.
Copy Download .nbib Format: NLM
[No title available]

MMW Fortschritte der Medizin

Westphal K.
PMID: 34146296
MMW Fortschr Med. 2021 Jun;163(12):66. doi: 10.1007/s15006-021-0129-8.

No abstract available.

Cite
Westphal K. Liegt eine linksventrikuläre Hypertrophie vor? . MMW Fortschr Med. 2021;163(12):66doi: 10.1007/s15006-021-0129-8.
Westphal, K. (2021). Liegt eine linksventrikuläre Hypertrophie vor? . MMW Fortschritte der Medizin, 163(12), 66. https://doi.org/10.1007/s15006-021-0129-8
Westphal, Kirsten. "Liegt eine linksventrikuläre Hypertrophie vor?" . MMW Fortschritte der Medizin vol. 163,12 (2021): 66. doi: https://doi.org/10.1007/s15006-021-0129-8
Westphal K. Liegt eine linksventrikuläre Hypertrophie vor? . MMW Fortschr Med. 2021 Jun;163(12):66. doi: 10.1007/s15006-021-0129-8. German. PMID: 34146296.
Copy Download .nbib Format: NLM
New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA.

Drug testing and analysis

Haschimi B, Grafinger KE, Pulver B, Psychou E, Halter S, Huppertz LM, Westphal F, Pütz M, Auwärter V.
PMID: 33788409
Drug Test Anal. 2021 Aug;13(8):1499-1515. doi: 10.1002/dta.3038. Epub 2021 May 05.

Synthetic cannabinoids (SCs) represent a large group of new psychoactive substances (NPS), sustaining a high prevalence on the drug market since their first detection in 2008. Cumyl-CBMICA and Cumyl-CBMINACA, the first representatives of a new subclass of SCs characterized...

Cite
Haschimi B, Grafinger KE, Pulver B, et al. New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA. Drug Test Anal. 2021;13(8):1499-1515doi: 10.1002/dta.3038.
Haschimi, B., Grafinger, K. E., Pulver, B., Psychou, E., Halter, S., Huppertz, L. M., Westphal, F., Pütz, M., & Auwärter, V. (2021). New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA. Drug testing and analysis, 13(8), 1499-1515. https://doi.org/10.1002/dta.3038
Haschimi, Belal, et al. "New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA." Drug testing and analysis vol. 13,8 (2021): 1499-1515. doi: https://doi.org/10.1002/dta.3038
Haschimi B, Grafinger KE, Pulver B, Psychou E, Halter S, Huppertz LM, Westphal F, Pütz M, Auwärter V. New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA. Drug Test Anal. 2021 Aug;13(8):1499-1515. doi: 10.1002/dta.3038. Epub 2021 May 05. PMID: 33788409.
Copy Download .nbib Format: NLM
Closed loop communication using provider team-specific smartphones improves the critical laboratory value notification process in paediatric inpatients.

BMJ open quality

Heneghan M, Westphal K, Bergman L, Falkiner R, Filipova L, Geisler S, Kendrich C, Martinez J, Malone S, Haymond S, Callas D, MacQuarrie KL.
PMID: 34521622
BMJ Open Qual. 2021 Sep;10(3). doi: 10.1136/bmjoq-2021-001420.

No abstract available.

Cite
Heneghan M, Westphal K, Bergman L, et al. Closed loop communication using provider team-specific smartphones improves the critical laboratory value notification process in paediatric inpatients. BMJ Open Qual. 2021;10(3)doi: 10.1136/bmjoq-2021-001420.
Heneghan, M., Westphal, K., Bergman, L., Falkiner, R., Filipova, L., Geisler, S., Kendrich, C., Martinez, J., Malone, S., Haymond, S., Callas, D., & MacQuarrie, K. L. (2021). Closed loop communication using provider team-specific smartphones improves the critical laboratory value notification process in paediatric inpatients. BMJ open quality, 10(3), . https://doi.org/10.1136/bmjoq-2021-001420
Heneghan, Mallorie, et al. "Closed loop communication using provider team-specific smartphones improves the critical laboratory value notification process in paediatric inpatients." BMJ open quality vol. 10,3 (2021). doi: https://doi.org/10.1136/bmjoq-2021-001420
Heneghan M, Westphal K, Bergman L, Falkiner R, Filipova L, Geisler S, Kendrich C, Martinez J, Malone S, Haymond S, Callas D, MacQuarrie KL. Closed loop communication using provider team-specific smartphones improves the critical laboratory value notification process in paediatric inpatients. BMJ Open Qual. 2021 Sep;10(3). doi: 10.1136/bmjoq-2021-001420. PMID: 34521622; PMCID: PMC8442100.
Copy Download .nbib Format: NLM
[No title available]

MMW Fortschritte der Medizin

Westphal K.
PMID: 33710577
MMW Fortschr Med. 2021 Mar;163(5):71. doi: 10.1007/s15006-021-9721-1.

No abstract available.

Cite
Westphal K. Alirocumab kommt wieder. . MMW Fortschr Med. 2021;163(5):71doi: 10.1007/s15006-021-9721-1.
Westphal, K. (2021). Alirocumab kommt wieder. . MMW Fortschritte der Medizin, 163(5), 71. https://doi.org/10.1007/s15006-021-9721-1
Westphal, Kirsten. "Alirocumab kommt wieder." . MMW Fortschritte der Medizin vol. 163,5 (2021): 71. doi: https://doi.org/10.1007/s15006-021-9721-1
Westphal K. Alirocumab kommt wieder. . MMW Fortschr Med. 2021 Mar;163(5):71. doi: 10.1007/s15006-021-9721-1. German. PMID: 33710577.
Copy Download .nbib Format: NLM
Showing 133 to 142 of 142 entries